SavedAdd your journal

Journals / MN Oftalmoloji / 2008 / Cilt: 15 - Sayı: 3

Pseudoexfoliation and diabetes mellitus

Psödoeksfolyasyon ve diabetes mellitus

Oya TEKELİ
M. Erol TURAÇLI
Osman İNCEL
FİLİZ ÖZDEMİR
Pages
163–165
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: These results indicate that the frequency of PEX is similar between DM and healthy subjects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim:To detect the frequency of pseudoexfoliation (PEX) in diabetes mellitus (DM).
📊
Key Findings & Data:Material and Method: This study consisted of 202 patients with or without diabetic retinopathy (DR) and 119 healthy subjects.
💡
Conclusion & Impact:Conclusion: These results indicate that the frequency of PEX is similar between DM and healthy subjects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim:To detect the frequency of pseudoexfoliation (PEX) in diabetes mellitus (DM). Material and Method: This study consisted of 202 patients with or without diabetic retinopathy (DR) and 119 healthy subjects. All participants underwent a complete ophthalmic examination. Results: There was no statistically significant difference in patient and control group for the age and gender (p>0.05). PEX syndrome was present in 11.9% of DM patients (n:24) and 17.6% of control subjects(n:21). PEX glaucoma was detected in 3.5% of DM patients (n:7) and 4.2 % of controls (n:5). The difference between patients with DR and patients without DR with regard to the frequency of PEX was not statistically significant (p>0.05). Conclusion: These results indicate that the frequency of PEX is similar between DM and healthy subjects.

Özet

Amaç: Diabetes mellituslu (DM) olgularda psödoeksfolyasyon (PEX) sıklığını saptamak. Gereç ve yöntem: Diabetik retinopatisi olan veya olmayan 202 DM hastası ve 119 sağlıklı olgu çalışmaya alındı. Tüm olgulara tam bir oftalmolojik muayene yapıldı. Bulgular: Her 2 grup arasında yaş ve cinsiyet açısından anlamlı fark saptanmadı. DM grubunun %11.9’da (n:24), kontrol grubunun % 17.6’da (n:21) psödoeksfolyasyon sendromu mevcuttu. Psödoeksfolyatif glokom ise hasta grubunun %3.5 (n:7), kontrol grubunun %4.2’sinde (n:5) bulundu. Nonproliferatif ve proliferatif diabetik retinopatisi olanlar arasında psödoeksfolyasyon sendromu veya glokomu açısından anlamlı fark yoktu (p>0.05). Sonuç: Bu bulgular DM ve sağlıklı kişiler arasında PEX sıklığının benzer olduğunu göstermektedir.

🔖

Cite This Article

TEKELİ, O., TURAÇLI, M. E., İNCEL, O., ÖZDEMİR, F. (2008). Pseudoexfoliation and diabetes mellitus. MN Oftalmoloji, Cilt: 15 - Sayı: 3, 163–165. https://ajindex.com/articles/295860

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Netland PA, Ye H, Streeten BW, et al. Elastosis of the lam ina cribrosa in pseudoexfoliation syndrome with glaucoma. Ophthalmology 1995; 102:876-86
  2. Naumann GOH, Schlötzer-Schrehardt U, Küchle M. Pseu doexfoliation syndrome for the comprehensive ophthalmolo gist. Intraocular and systemic manifestations. Ophthalmology 1998;105:951-68
  3. Ritch R,Schlötzer-Schrehardt U.Exfoliation Syndrome. Surv Ophthalmol 2001;45:265-315
  4. Streeten BW, Li ZY, Wallace RN. Pseudoexfoliative fibrillopa thy in visceral organs of a patient with pseudoexfoliation syn drome. Arch Ophthalmol 1992; 110:1757-62
  5. Sollosy M.Incidence of the uveal pseudoexfoliation syndrome in patients with diabetes mellitus. Oftalmologla 2004;48:76-80 6. Sainz Gomez O, Moreno-Montanes J, Escudero Berasatequi JM, Sabada Echarri LM, Fernandez Hortelano A, Garcia Loyana A: Prevalence and risk factors of pseudoexfoliation syndrome in institutionalized geriatric patients in Navara. Arch Soc Esp Ophthalmol 2003;78:383-8 7. Psilas KG, Stefaniotou MJ, Aspiotis MB. Pseudoexfoliation syndrome and diabetes meliitus. Acta Ophthalmol (Copenh). 1991;69:664-6